Swedbank
ALNY icon

Swedbank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Swedbank’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6M Sell
61,894
-321
-0.5% -$96.8K 0.02% 414
2026
Q1 		$20.6M Buy
62,215
+273
+0.4% +$92.9K 0.02% 368
2025
Q4 		$24.6M Sell
61,942
-1,636
-3% -$724K 0.02% 351
2025
Q3 		$29M Sell
63,578
-737
-1% -$300K 0.03% 313
2025
Q2 		$21M Buy
64,315
+4,322
+7% +$1.2M 0.02% 357
2025
Q1 		$16.2M Buy
59,993
+4,461
+8% +$1.15M 0.02% 390
2024
Q4 		$13.1M Buy
55,532
+1,803
+3% +$474K 0.02% 425
2024
Q3 		$14.8M Buy
53,729
+33,090
+160% +$8.62M 0.02% 402
2024
Q2 		$5.02M Hold
20,639
– – 0.01% 534
2024
Q1 		$3.08M Sell
20,639
-200,000
-91% -$33.4M ﹤0.01% 573
2023
Q4 		$42.2M Hold
220,639
– – 0.07% 203
2023
Q3 		$39.1M Sell
220,639
-113,303
-34% -$21.6M 0.07% 198
2023
Q2 		$63.4M Hold
333,942
– – 0.11% 159
2023
Q1 		$66.9M Sell
333,942
-92,711
-22% -$19.5M 0.13% 144
2022
Q4 		$101M Buy
426,653
+10,593
+3% +$2.26M 0.22% 98
2022
Q3 		$83.3M Sell
416,060
-23,152
-5% -$4.42M 0.2% 103
2022
Q2 		$64.1M Buy
439,212
+856
+0.2% +$121K 0.14% 139
2022
Q1 		$71.6M Buy
438,356
+1,791
+0.4% +$273K 0.13% 144
2021
Q4 		$74.7M Buy
436,565
+67
+0% +$12.5K 0.12% 149
2021
Q3 		$82.4M Buy
436,498
+90,986
+26% +$17.1M 0.15% 129
2021
Q2 		$58.6M Buy
345,512
+5,193
+2% +$761K 0.11% 174
2021
Q1 		$48M Buy
+340,319
New +$51.2M 0.1% 190

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swedbank's ALNY Position: Q2 2026 in Review

Swedbank reduced its Alnylam Pharmaceuticals (ALNY) stake by 0.52% in Q2 2026, selling an estimated $96.8K and leaving 61,894 shares worth $18.6M. The position accounts for 0.02% of the portfolio, ranked #414.

Swedbank first reported a position in ALNY in Q1 2021 and has held it in 22 quarters since. The position peaked at $101M in Q4 2022. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Swedbank held 61,894 shares of Alnylam Pharmaceuticals worth $18.6M as of Q2 2026.
  • Swedbank sold 321 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $96.8K.
  • Alnylam Pharmaceuticals made up 0.02% of Swedbank's portfolio in Q2 2026, its #414 holding.
  • Swedbank first reported a position in Alnylam Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Swedbank's Alnylam Pharmaceuticals position peaked at $101M in Q4 2022.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.